International reference: 2 US FDA recalls for this ingredient
CGMP Deviations: Firm went out of business and could no longer continue stability studies. (ciclopirox)
Failed Degradation/Impurities Specifications: Out of specification related substance results during stability testing. (ciclopirox)
US-market enforcement records (OpenFDA), shown for reference - not specific to this product in Kenya.
CICLDENT SHAMPOO
CICLOPIROX USP
What it does
Ciclopirox is a topical antifungal medication used to treat skin infections.
Commonly used for: fungal skin infections, tinea (ringworm), athlete's foot (tinea pedis), jock itch (tinea cruris) …
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.
Source this medicineRegistration & product details
Source: Pharmacy and Poisons Board · fetched 2026-01-28 21:47:32 · updated 2026-03-23 04:32:37
About this medicine
Ciclopirox is a topical antifungal medication used to treat skin infections.
What it treats
- fungal skin infections
- tinea (ringworm)
- athlete's foot (tinea pedis)
- jock itch (tinea cruris)
- fungal nail infections (onychomycosis)
How it works
Ciclopirox works by stopping the growth of fungi on the skin and nails.
Who it's for
Ciclopirox is suitable for adults and children who have fungal infections affecting the skin or nails.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: ciclopirox
BNF-referencedCiclopirox is a broad-spectrum antifungal agent that possesses antibacterial and anti-inflammatory properties. It is primarily used to treat fungal infections of the skin and nails. Ciclopirox distinguishes itself from other antifungals by its unique mechanism of action involving the chelation of metal cations, which disrupts various cellular processes in fungi and bacteria.
Indications
- Fungal infections of the skin
- Onychomycosis (fungal nail infections)
- Seborrheic dermatitis
- Tinea corporis (ringworm of the body)
- Tinea pedis (athlete's foot)
Dosage
Children: For children, the dosage is typically determined by the pediatrician; refer to the BNF for Children for specific dosing guidance.
Adults: For topical use, ciclopirox is usually applied once or twice daily to the affected area. Refer to the BNF for specific formulations and treatment duration.
Mechanism of action
Ciclopirox acts through the chelation of polyvalent metal cations, such as Fe3+ and Al3+, which inhibit essential enzymes, including cytochromes. This disruption affects mitochondrial electron transport and energy production within the cell. Additionally, ciclopirox modifies the plasma membrane of fungi, leading to disorganization of internal structures. Its anti-inflammatory properties are attributed to the inhibition of 5-lipoxygenase and cyclooxygenase, as well as impacts on DNA repair and cell division.
Pharmacodynamics
Ciclopirox demonstrates broad-spectrum antifungal activity, exhibiting either fungistatic or fungicidal effects against a variety of fungal organisms, including dermatophytes, yeasts, and actinomycetes. It also has significant antibacterial activity against both Gram-positive and Gram-negative bacteria. The anti-inflammatory effects are evident in its ability to inhibit the synthesis of prostaglandins and leukotrienes in human polymorphonuclear cells.
Pharmacokinetics
Ciclopirox is well-absorbed when applied topically, with systemic absorption being minimal. It has a relatively low systemic bioavailability when used as a topical treatment. The pharmacokinetics of ciclopirox may vary based on the formulation and site of application. It is primarily metabolized in the liver, with excretion occurring via the urine.
Pregnancy
Ciclopirox should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus.
Breast-feeding
Ciclopirox is excreted in breast milk. Caution should be exercised when prescribing to nursing mothers.
Storage
Store in a cool, dry place away from direct sunlight. Keep out of reach of children.
Formulations
- Topical solution
- Cream
- Gel
- Shampoo
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Molecular reference: ciclopirox
PubChem CID 2749Molecular formula: C12H17NO2
Mechanism of action
Unlike antifungals such as itraconazole and terbinafine, which affect sterol synthesis, ciclopirox is thought to act through the chelation of polyvalent metal cations, such as Fe<sup>3+</sup> and Al<sup>3+</sup>. These cations inhibit many enzymes, including cytochromes, thus disrupting cellular activities such as mitochondrial electron transport processes and energy production. Ciclopirox also appears to modify the plasma membrane of fungi, resulting in the disorganization of internal structures. The anti-inflammatory action of ciclopirox is most likely due to inhibition of 5-lipoxygenase and cyclooxygenase. ciclopirox may exert its effect by disrupting DNA repair, cell division signals and structures (mitotic spindles) as well as some elements of intracellular transport.
Pharmacodynamics
Ciclopirox is a broad-spectrum antifungal medication that also has antibacterial and anti-inflammatory properties. Its main mode of action is thought to be its high affinity for trivalent cations, which inhibit essential co-factors in enzymes. Ciclopirox exhibits either fungistatic or fungicidal activity in vitro against a broad spectrum of fungal organisms, such as dermatophytes, yeasts, dimorphic fungi, eumycetes, and actinomycetes. In addition to its broad spectrum of action, ciclopirox also exerts antibacterial activity against many Gram-positive and Gram-negative bacteria. Furthermore, the anti-inflammatory effects of ciclopirox have been demonstrated in human polymorphonuclear cells, where ciclopirox has inhibited the synthesis of prostaglandin and leukotriene. Ciclopirox can also exhibit its anti-inflammatory effects by inhibiting the formation of 5-lipoxygenase and cyclooxygenase.
Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.